fluoxetine has been researched along with clomipramine in 257 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (15.56) | 18.7374 |
| 1990's | 122 (47.47) | 18.2507 |
| 2000's | 54 (21.01) | 29.6817 |
| 2010's | 39 (15.18) | 24.3611 |
| 2020's | 2 (0.78) | 2.80 |
| Authors | Studies |
|---|---|
| Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP | 1 |
| Anderson, VB; Geyer, HM; Kruse, H; Ong, HH; Profitt, JA; Wilker, JC | 1 |
| Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Eid, NM; George, RF; Hanna, MM; Safwat, HM | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Bawa, S; Drabu, S; Gupta, H; Kumar, R; Kumar, S; Machwal, L | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Choi, K; Moon, B; Park, JE; Roh, EJ; Sim, T; Song, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chern, YF; Chow, CF; Li, YP; Lin, MT | 1 |
| Tseng, LF | 2 |
| Fuller, RW; Perry, KW | 1 |
| Dawsey, WJ; Geyer, MA; Mandell, AJ | 1 |
| Mishra, R; Sulser, F | 1 |
| Lin, MT | 1 |
| Gershon, MD; Jonakait, GM | 1 |
| Chern, SI; Chern, YF; Lin, MT; Pang, IH | 1 |
| Frazer, A; Mendels, J; Savage, DD | 1 |
| Kriete, M; Rapoport, JL; Ryland, DH | 1 |
| Anthony, DT; Fallon, BA; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR; Stein, DJ | 1 |
| Artigas, F; Ortiz, J | 1 |
| Hart, LL; Maruno, CA | 1 |
| Dominguez, RA | 1 |
| Cohen, LJ; Grothe, DR | 1 |
| Bertschy, G; Bizouard, P; Bonin, B; François, TH; Nezelof, S; Sechter, D; Vandel, B; Vandel, S | 1 |
| Carrasco, JL; Hollander, E; Liebowitz, MR; Schneier, FR | 1 |
| Costa, D | 1 |
| Bernardo, M; Vieta, E | 1 |
| Goldberger, EL; Grady, CL; Leonard, HL; Pietrini, P; Rapoport, JL; Rapoport, SI; Rettew, DC; Schapiro, MB; Swedo, SE | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 3 |
| Kindler, S; Zohar, J | 1 |
| Hollander, E; Stein, DJ | 1 |
| Hollander, E; McCarley, A | 1 |
| Gitow, A; Graae, F; Jaffer, M; Liebowitz, M; Piacentini, J | 1 |
| Casey, DA | 1 |
| Alarcon, RD; Johnson, BR; Lucas, JP | 1 |
| Ledwidge, B; Solyom, C; Solyom, L | 1 |
| Arató, M; MacCrimmon, DJ | 1 |
| George, MS | 1 |
| Altuna, R; Alvarez, E; Ayuso, JL; Casais, L; Noguera, R; Udina, C | 1 |
| Austin, LS; Lydiard, RB; Zealberg, JJ | 1 |
| Mavissakalian, MR; Tamimi, RR | 1 |
| Dysken, MW; Kim, SW | 1 |
| Grossman, M; Naylor, MW | 1 |
| Burd, L; Kerbeshian, J | 1 |
| Dossenbach, M; Pakesch, G | 1 |
| Bihari, K; Hill, JL; Murphy, DL; Pato, MT | 1 |
| DeCaria, CM; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR; Schneier, HA | 1 |
| DeCaria, C; Fairbanks, J; Fallon, B; Hollander, E; Klein, DF; Liebowitz, MR | 1 |
| Insel, TR | 1 |
| Baer, L; Greist, JH; Jenike, MA | 1 |
| Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P | 1 |
| Bernstein, SE; Grover, GN; Hill, JL; Murphy, DL; Pato, MT; Pigott, TA; Tolliver, TJ | 1 |
| Campeas, RB; Fairbanks, J; Fallon, BA; Hatterer, JA; Hollander, E; Liebowitz, MR; Papp, LA; Sandberg, D; Schneier, FR | 1 |
| Simeon, JG; Thatte, S; Wiggins, D | 1 |
| Dellafera, SS; Fernandes, R; Kranzler, H; Wong, SH | 1 |
| Cohen, DL; Hanahoe, TH; Purcell, WM | 1 |
| Greist, JH; Johnston, H; March, JS | 1 |
| de la Gandara, J; Dominguez, RA; Goldstein, BJ; Jacobson, AF; Steinbook, RM | 1 |
| Ginestet, D | 1 |
| Agnoli, A; Manna, V; Martucci, N | 1 |
| Ropert, R | 1 |
| Hollander, E; Klein, DF; Klumker, A; Liebowitz, MR; Winchel, R | 1 |
| Goldstein, FJ; Kellstein, DE; Malseed, RT; Ossipov, MH | 1 |
| Fuller, RW | 1 |
| Mash, DC; Soliman, KF; Walker, CA | 1 |
| Hrdina, PD | 1 |
| Collard, KJ; Evans, SM | 1 |
| Fontaine, R; Primeau, F | 1 |
| Chouinard, G; Fontaine, R | 1 |
| Chuang, DM; Costa, E; Nakaki, T; Roth, BL | 1 |
| Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
| Katz, DM; Kimelberg, HK | 1 |
| Fan, YC; Lin, MT; Tsay, BL | 1 |
| Fennessy, MR; Taylor, DA; Verberne, AJ | 1 |
| Bardakdjian, J; Costa, MF; Fages, C; Gonnard, P; Tardy, M | 1 |
| Carlà, V; Galli, A; Magnani, M; Sgaragli, G | 1 |
| Broitman, ST; Fóscolo, MR; Rodríguez Echandía, EL | 1 |
| Carter, RB; Leander, JD | 1 |
| Buckholtz, NS; Sparks, DL | 1 |
| Meierl, G; Schmidt, WJ | 1 |
| Glusman, S; Haber, B; Ritchie, T | 1 |
| Algeri, S; Brunello, N; Curatolo, L; Dolfini, E; Locati, M; Mella, L; Mennini, T; Morasca, L; Salmona, AL; Vaghi, M | 1 |
| Hackett, LP; Ilett, KF; Pinder, M; Power, BM | 1 |
| Baker, GB; McManus, DJ; Todd, KG | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Aronowitz, B; Cohen, LJ; Hollander, E; Rosen, J; Simeon, D; Spadaccini, E; Stein, DJ | 1 |
| Volk, S | 1 |
| Barzega, G; Bellino, S; Bogetto, F; Maina, G; Ravizza, L | 3 |
| Allen, AJ; Leonard, H; Swedo, SE | 1 |
| Benfield, P; Harris, MG | 1 |
| Sternbach, H | 1 |
| Blackburn, TP; de Biasi, V; Kennett, GA; Lightowler, S; Stevens, NC; Tulloch, IF; Wood, MD | 1 |
| Althof, SE | 1 |
| Greist, JH; Jefferson, JW; Katzelnick, DJ; Kobak, KA; Serlin, RC | 1 |
| Corbett, R; Cornfeldt, M; Dunn, RW; Smith, C; Szewczak, M; Woods, A | 1 |
| Haenel, T; Stöckli, HR; Truog, P | 1 |
| Leonard, HL; Swedo, SE | 1 |
| Bianchi, M; Panerai, AE; Sacerdote, P | 1 |
| Dominguez, RA; Mestre, SM | 1 |
| Baer, L; Buttolph, ML; Jenike, MA; Keuthen, N; Minichiello, W; Otto, M; Pettit, AR; Ricciardi, J | 1 |
| Deltito, JA | 1 |
| Gilbert, P; Lopez, WM; Paulsen, J; Sewell, DD | 1 |
| Mattes, JA | 1 |
| Jackson, CW; Lydiard, RB; Morton, WA | 1 |
| McElroy, SL; Phillips, KA | 1 |
| Cox, BJ; Lee, PS; Morrison, B; Swinson, RP | 1 |
| Potvin, JH; Souetre, E; Thomander, L; Tollefson, GD | 1 |
| Azari, NP; Horwitz, B; Leonard, HL; Pettigrew, KD; Pietrini, P; Rapoport, JL; Schapiro, MB; Swedo, SE | 1 |
| Hollander, E; Josephson, SC; Stein, DJ | 1 |
| Balon, R; Pohl, R; Ramesh, C; Yeragani, VK | 1 |
| DeCaria, CM; Hollander, E; Klein, DF; Liebowitz, MR; Saoud, JB; Stein, DJ | 1 |
| Bellodi, L; Mundo, E; Ronchi, P | 1 |
| Hagan, MM; Moss, DE | 1 |
| Hudson, JI; Keck, PE; McElroy, SL; Phillips, KA; Pope, HG | 1 |
| Cohen, LS; Dimmock, JA; Rosenbaum, JF; Sichel, DA | 1 |
| Herpertz-Dahlmann, B | 1 |
| Browne, M; Horn, E; Jones, TT | 1 |
| Ichikawa, J; Meltzer, HY | 1 |
| Gambarana, C; Ghiglieri, O; Graziella de Montis, M | 1 |
| Jarry, JL; Vaccarino, FJ | 1 |
| Sandler, NH | 1 |
| Berti, F; Bianchi, M; Panerai, AE; Rossoni, G; Sacerdote, P | 1 |
| Aizenberg, D; Weizman, A; Zemishlany, Z | 1 |
| Katz, G; Nijhawan, PK; Winter, S | 1 |
| Baumann, P; Bertschy, G; Bizouard, P; Bonin, B; Bouquet, S; Francois, T; Sechter, D; Vandel, S | 1 |
| Erjavec, F; Ferjan, I | 1 |
| Lozet, H; Martin, P; Monteban, H; Souêtre, E | 1 |
| Balon, R | 1 |
| Allilaire, JF; el Massioui, F; Martinerie, J; Müller, J; Nandrino, JL; Pezard, L; Renault, B; Varela, F | 1 |
| Koran, LM; Maloney, A; Mueller, K | 1 |
| Bourgeois, M; Cottraux, J; Gómez-Pérez, JC; Hernández, M; López-Ibor, JJ; Note, I; Saiz, J; Viñas, R | 1 |
| Balant, LP; Balant-Gorgia, AE; Ries, C | 1 |
| Berk, M; Koopowitz, LF; Szabo, CP | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| Iancu, I; Kindler, S; Sasson, Y; Weizman, A; Zohar, J | 1 |
| Rey, JM; Wever, C | 1 |
| Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Molaie, M | 1 |
| Aymard, G; Diquet, B; Livi, P; Pham, YT | 1 |
| Bisserbe, JC; Flament, MF | 1 |
| Dominguez, RA; Puig, A | 1 |
| Antelman, SM; Gershon, S | 1 |
| Evanoff, A; Newton, WP | 1 |
| Kim, SC; Seo, KK | 1 |
| Nutt, DJ | 1 |
| Chang, HC; Cheng, JT; Hsieh, CH; Hsieh, JT; Law, HS | 1 |
| Chen, JX; Gershon, MD; Pan, H; Rothman, TP; Wade, PR | 1 |
| Benazzi, F | 1 |
| Meyers, BS | 1 |
| de la Sablonnière, JF; Mottard, JP | 1 |
| Trappler, B | 1 |
| Boyer, P | 1 |
| Baer, L; Jenike, MA; Manzo, PA; Mataix-Cols, D; Rauch, SL | 1 |
| Salama, AA; Salama, SA | 1 |
| Ackerman, DL; Bystritsky, A; Greenland, S | 1 |
| Boeijinga, PH; d'Ardhuy, XL; Luthringer, R; Macher, J; Renault, B; Rinaudo, G; Soufflet, L; Toussaint, M | 1 |
| Alvarez, JC; Arnulf, I; Gluck, N; Launay, JM; Leboyer, M; Pecquery, R; Perez-Diaz, F; Quintin, P; Spreux-Varoquaux, O | 1 |
| Advenier, C; Alvarez, JC; Sanceaume, M; Spreux-Varoquaux, O | 1 |
| McMahon, CG; Samali, R | 1 |
| Borgeat, F; Freeston, MH; Todorov, C | 1 |
| Han, JH; Kim, SC; Lee, MY; Seo, KK | 1 |
| Aguas Nuevo, E; Berzas Nevado, JJ; Contento Salcedo, AM; Villaseñor Llerena, MJ | 1 |
| Judge, R; Montgomery, SA | 1 |
| Manev, H; Manev, R; Smalheiser, NR; Uz, T | 1 |
| Kim, SC; Lee, MY; Seo, KK | 1 |
| Schenberg, LC; Vargas, LC | 1 |
| Cavagnini, F; Clemente, A; Ferrari, VM; Laini, V; Lugo, F; Mantero, M; Mauri, MC; Redaelli, G; Ruggiero, GM; Zappulli, D | 1 |
| Guralnik, O; Schmeidler, J; Simeon, D | 1 |
| Alonso, P; Mataix-Cols, D; Menchon, JM; Pifarre, J; Salgado, P; Torres, L; Vallejo, J | 1 |
| Al-Sughayir, MA | 1 |
| Ferris, CF; Koppel, G; Messenger, T; Rasmussen, MF | 1 |
| Capucho, LB; Schenberg, LC; Vargas, LC; Vatanabe, RO | 1 |
| Ghafourifar, P; Mousavizadeh, K; Sadeghi-Nejad, H | 1 |
| Sugimoto, Y; Yamada, J | 1 |
| Paholpak, S | 1 |
| Safranko, I | 1 |
| Abdel-Salam, OM; El-Shenawy, SM; Nofal, SM | 1 |
| Corda, MG; Driscoll, P; Giorgi, O; Hansson, S; Lecca, D; Piras, G | 1 |
| Joyce, PR; Luty, SE; Mulder, RT; Watkins, WG | 1 |
| Dean-McKinney, T; Klausner, AP; Lee, KS; Na, YG; Steers, WD; Tuttle, JB | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Bernal-Morales, B; Contreras, CM; Gutiérrez-García, AG; Rodríguez-Landa, JF | 1 |
| Anderson, GM; Dodson, AM; Rhoden, KJ | 1 |
| Kim, SW; Lee, SH; Paick, JS | 1 |
| Broly, F; Haffen, E; Kantelip, JP; Nezelof, S; Sechter, D; Vandel, P | 1 |
| Fernández-Guasti, A; Martínez-Mota, L | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Nangle, DW; O'Grady, AC; Sallinen, BJ | 1 |
| Bonilla-Jaime, H; Vázquez-Palacios, G; Velázquez-Moctezuma, J | 1 |
| Bergman, L; Cliff, KD; Hart, BL; Tynes, VV | 1 |
| Chen, JY; Chen, YA; Tao, PL; Wu, CC; Yeh, GC | 1 |
| Barnes, NM; Blakely, RD; Bunce, CM; Challa, A; Chamba, A; Drake-Lee, A; Drayson, MT; Dyer, MJ; Gordon, J; Holder, MJ; Meredith, EJ; Pilkington, G | 1 |
| Adkins, EM; Blakely, RD; Field, JR; Henry, LK; Newman, AH; Parnas, ML; Vaughan, RA; Zou, MF | 1 |
| Anderson, SW; Booker, MB | 1 |
| Alonso, P; Jiménez, S; Labad, J; Menchón, JM; Segalàs, C; Vallejo, J | 1 |
| Alenezi, AM; BaHammam, AS | 1 |
| Carlini, VP; de Barioglio, SR; Gaydou, RC; Schiöth, HB | 1 |
| Rybakowski, JK; Łojko, D | 1 |
| Abdel-Razaq, W; Bates, TE; Kendall, DA | 2 |
| Fineberg, NA; Ipser, J; Pallanti, S; Pampaloni, I; Stein, DJ | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Holman, JR; Kimmer, SL; Lo, V; Mercado, MG; Wanserski, G | 1 |
| Sharma, H | 1 |
| Zargooshi, J | 1 |
| Ipser, JC; Sander, C; Stein, DJ | 1 |
| Bloch, MH; Coric, V; Dombrowski, P; Goodman, WK; Kelmendi, B; Krystal, JH; Landeros-Weisenberger, A; Leckman, JF; Nudel, J; Pittenger, C; Wegner, R | 1 |
| Birowo, P; Jonas, U; Kedia, GT; Kuczyk, MA; Meyer, M; Rahardjo, D; Scheller, F; Taher, A; Uckert, S | 1 |
| Arteaga-Silva, M; Bonilla-Jaime, H; Hernández-González, M; Retana-Márquez, S; Vázquez-Palacios, G | 1 |
| Barnes, NM; Chamba, A; Drayson, MT; Gordon, J; Holder, MJ; Jarrett, RF; Shield, L; Toellner, KM | 1 |
| Corda, MG; Giorgi, O; Piras, G | 1 |
| Bult-Ito, A; Burrow, T; Castillo, MR; Foltz, H; Greene-Schloesser, DM; Gregg, KA; Sheppard, DK; Slater, M; Van der Zee, EA | 1 |
| Landsberg, GM; Mills, DS; Redgate, SE | 1 |
| Barros, S; de Carvalho, J | 1 |
| Diniz, JB; Fossaluza, V; Koran, L; Miguel, EC; Pereira, CA; Shavitt, RG | 1 |
| Araujo Escalona, AG; Estrada-Reyes, R; Heinze, G; Ledesma Velázquez, I; Martínez-Mota, L; Martínez-Vázquez, M; Moreno, J | 1 |
| Okada, T | 1 |
| Andrade, C | 1 |
| Corda, MG; Giorgi, O; Piludu, MA; Piras, G | 1 |
| Cassab, RC; Costa, DL; Diniz, JB; Miguel, EC; Pereira, CA; Shavitt, RG | 1 |
| Asbahr, FR; da Costa, CZ; de Morais, RM; Labbadia, EM; Lotufo Neto, F; Morikawa, M; Rodrigues, CL; Turkiewicz, G; Zanetta, DM | 1 |
| Fink-Gremmels, J; Schrickx, JA | 1 |
| Derry, S; Hearn, L; Moore, RA; Phillips, T; Wiffen, PJ | 1 |
| Alves, V; Câmara, JS; Conceição, C; Gonçalves, J; Teixeira, HM | 2 |
| Delgermurun, D; Ito, S; Ohta, T; Otsuguro, K; Yamaguchi, S | 1 |
| Dao-Ung, P; Fuller, SJ; Skarratt, KK; Stokes, L | 1 |
| Garg, K; Kar, SK | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Aggour, AM; Al-Ghafari, A; Almutairi, FM; Carter, WG; Elmorsy, E | 1 |
| Bhave, S; Faye, A; Gawande, S; Kirpekar, V; Tadke, R | 1 |
| Asadi-Pooya, AA; Firouzabadi, N; Kashkooli, M; Malekpour, M; Zamiri, B | 1 |
| Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
43 review(s) available for fluoxetine and clomipramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Buspirone in obsessive-compulsive disorder.
Topics: Adult; Buspirone; Clinical Trials as Topic; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder | 1992 |
Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
Topics: Clomipramine; Double-Blind Method; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1992 |
Major depression: its recognition and treatment. Part 2. Second-generation and newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Clomipramine; Depression; Female; Fluoxetine; Humans; Male; Maprotiline; Selective Serotonin Reuptake Inhibitors; Trazodone | 1992 |
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
Topics: Brain; Clomipramine; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Serotonin; Tourette Syndrome | 1992 |
Serotonergic probes in obsessive compulsive disorder.
Topics: Brain; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Receptors, Serotonin; Serotonin | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
Obsessive-compulsive disorder. Characteristic features, pharmacologic management.
Topics: Clomipramine; Fluoxetine; Humans; Obsessive-Compulsive Disorder | 1992 |
Obsessive-compulsive disorder.
Topics: Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder | 1991 |
New pharmacologic approaches to obsessive compulsive disorder.
Topics: Behavior Therapy; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Oximes | 1990 |
Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies | 1990 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Treatment of body-dysmorphic disorder with serotonin reuptake blockers.
Topics: Adult; Body Image; Clomipramine; Diagnosis, Differential; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Somatoform Disorders | 1989 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
[Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
Topics: Clomipramine; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Treatment Outcome | 1995 |
Current knowledge of medications for the treatment of childhood anxiety disorders.
Topics: Adolescent; Age of Onset; Anti-Anxiety Agents; Anxiety Disorders; Child; Clomipramine; Fluoxetine; History, 20th Century; Humans; Obsessive-Compulsive Disorder | 1995 |
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
Topics: Aged; Amitriptyline; Clomipramine; Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Receptors, Adrenergic; Suicide | 1995 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Childhood movement disorders and obsessive compulsive disorder.
Topics: Antipsychotic Agents; Child; Chorea; Clinical Trials as Topic; Clomipramine; Comorbidity; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome; Treatment Outcome | 1994 |
Management of treatment-refractory obsessive compulsive disorder patients.
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Clonazepam; Combined Modality Therapy; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Treatment Outcome | 1994 |
Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis.
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Treatment Outcome | 1993 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
[Serotonergic antidepressants--indications for treating children and adolescents exemplified by fluoxetine and clomipramine].
Topics: Adolescent; Child; Clomipramine; Fluoxetine; Humans; Mental Disorders | 1993 |
Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.
Topics: Anorexia Nervosa; Bulimia; Clomipramine; Comorbidity; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin | 1996 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Clinical application of time-dependent sensitization to antidepressant therapy.
Topics: Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Administration Schedule; Electroconvulsive Therapy; Fluoxetine; Humans; Time Factors; Triazolam | 1998 |
Antidepressants in panic disorder: clinical and preclinical mechanisms.
Topics: Antidepressive Agents; Clomipramine; Fluoxetine; Humans; Panic Disorder; Raphe Nuclei; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 1998 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Pharmacological treatment of premature ejaculation.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological | 1999 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
Pharmacotherapy and psychotherapy for body dysmorphic disorder.
Topics: Adrenergic Uptake Inhibitors; Body Image; Clomipramine; Cognitive Behavioral Therapy; Desipramine; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders | 2009 |
A meta-analysis of studies of treatments for feline urine spraying.
Topics: Animals; Behavior, Animal; Cat Diseases; Cats; Clinical Trials as Topic; Clomipramine; Fluoxetine; Follow-Up Studies; Pheromones; Placebos; Treatment Outcome; Urination | 2011 |
Pathological gambling and primary antiphospholipid (Hughes) syndrome: a unique neuropsychiatric association.
Topics: Antidepressive Agents; Antiphospholipid Syndrome; Antipsychotic Agents; Clomipramine; Clozapine; Fluoxetine; Fructose; Gambling; Humans; Male; Middle Aged; Topiramate | 2011 |
[The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
Topics: Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Clomipramine; Cognitive Behavioral Therapy; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors | 2011 |
Desipramine for neuropathic pain in adults.
Topics: Aged; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Chronic Pain; Clomipramine; Desipramine; Diabetic Neuropathies; Fluoxetine; Humans; Middle Aged; Neuralgia, Postherpetic; Randomized Controlled Trials as Topic | 2014 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
33 trial(s) available for fluoxetine and clomipramine
| Article | Year |
|---|---|
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer | 1992 |
Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
Topics: Clomipramine; Double-Blind Method; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1992 |
Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania.
Topics: Adult; Clomipramine; Comorbidity; Dopamine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Pimozide; Serotonin; Trichotillomania | 1992 |
Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.
Topics: Adult; Clomipramine; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Serotonin; Sexual Dysfunctions, Psychological; Yohimbine | 1992 |
Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1991 |
[Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners].
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Double-Blind Method; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Private Practice; Psychiatry | 1991 |
Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies | 1990 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
Topics: Adult; Blood Platelets; Clomipramine; Double-Blind Method; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Serotonin | 1990 |
Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
Topics: Adolescent; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychology, Adolescent | 1990 |
Fluoxetine in endogenous depression and melancholia versus clomipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Multicenter Studies as Topic | 1989 |
Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged | 1989 |
Fluoxetine versus clomipramine in major depressive disorders.
Topics: Adult; Chemical Phenomena; Chemistry; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1989 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Probability; Schizotypal Personality Disorder; Treatment Outcome | 1995 |
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Ambulatory Care; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prognosis; Prolactin; Serotonin Antagonists | 1993 |
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
Topics: Adult; Amitriptyline; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype | 1995 |
Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 1996 |
Serotonergic drugs in trichotillomania: treatment results in 12 patients.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Trichotillomania | 1996 |
Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Time Factors | 1996 |
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Double-Blind Method; Ejaculation; Fluoxetine; Humans; Male; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1998 |
Side effects as predictors of drug response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Anxiety; Clomipramine; Dose-Response Relationship, Drug; Ejaculation; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Obsessive-Compulsive Disorder; Orgasm; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sleep Initiation and Maintenance Disorders | 1999 |
Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Double-Blind Method; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Fluoxetine; Humans; Male; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiazepines | 1999 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics.
Topics: Adult; Amenorrhea; Amisulpride; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Body Image; Clomipramine; Diet Therapy; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Single-Blind Method; Sulpiride; Treatment Outcome; Weight Gain | 2001 |
Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
Topics: Adolescent; Adult; Age of Onset; Ambulatory Care; Behavior Therapy; Clomipramine; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Probability; Prognosis; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Age may affect response to antidepressants with serotonergic and noradrenergic actions.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Treatment Outcome | 2003 |
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Phenotype | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Control of urine marking by use of long-term treatment with fluoxetine or clomipramine in cats.
Topics: Administration, Oral; Animals; Behavior, Animal; Cat Diseases; Cats; Clomipramine; Drug Administration Schedule; Female; Fluoxetine; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Urination Disorders | 2005 |
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Follow-Up Studies; Humans; Middle Aged; Obsessive-Compulsive Disorder; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2011 |
The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Body Dysmorphic Disorders; Brazil; Clomipramine; Comorbidity; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Prospective Studies; Quetiapine Fumarate; Risk Factors; Treatment Outcome | 2014 |
Comparison among clomipramine, fluoxetine, and placebo for the treatment of anxiety disorders in children and adolescents.
Topics: Adolescent; Anxiety Disorders; Child; Clomipramine; Double-Blind Method; Female; Fluoxetine; Humans; Male; Placebos; Selective Serotonin Reuptake Inhibitors | 2013 |
185 other study(ies) available for fluoxetine and clomipramine
| Article | Year |
|---|---|
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine | 1987 |
Novel tetracyclic spiropiperidines. 1. 3-Aryl-1,3-dihydrospiro[benzo[c]thiophene-1,4'-piperidines] as potential antidepressants.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Tricyclic; Blepharoptosis; Chemical Phenomena; Chemistry; Drug Synergism; Male; Mice; Physostigmine; Piperidines; Spiro Compounds; Tetrabenazine | 1981 |
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes | 1997 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Citalopram; Clomipramine; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Mice; Molecular Structure; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tropanes; Yohimbine | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives.
Topics: Animals; Antidepressive Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Enzyme Inhibitors; Molecular Structure; Monascus; Monoamine Oxidase; Motor Activity; Penicillium; Quinolines; Rats; Rats, Wistar; Rotarod Performance Test; Stereoisomerism; Stress, Psychological; Structure-Activity Relationship; Swimming | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Lactams; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Pyrrolidinones; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2013 |
Effects of brain serotonin alterations on hypothermia produced by chlorpromazine in rats.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Animals; Body Temperature Regulation; Brain; Chlorpromazine; Clomipramine; Fenclonine; Fluoxetine; Hypothermia; Male; Nialamide; Propylamines; Raphe Nuclei; Rats; Serotonin; Tryptophan | 1979 |
Blockade of para-methoxyamphetamine induced serotonin release by serotonin uptake inhibitors.
Topics: Amphetamines; Animals; Brain; Clomipramine; Desipramine; Fluoxetine; Hydroxyindoleacetic Acid; Male; Muscle Contraction; Rats; Serotonin; Serotonin Antagonists | 1978 |
Effect of uptake inhibitors on the depletion of brain norepinephrine and serotonin after alpha-methyl-m-tyrosine administration to rats.
Topics: Animals; Brain Chemistry; Clomipramine; Drug Interactions; Fluoxetine; Male; Methyltyrosines; Norepinephrine; Protriptyline; Rats; Serotonin; Time Factors | 1978 |
Fading: a new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular level in brain.
Topics: Animals; Brain; Brain Chemistry; Brain Mapping; Clomipramine; Dopamine; Extracellular Space; Fenfluramine; Fluoxetine; Histocytochemistry; Lysergic Acid Diethylamide; Male; Norepinephrine; Pargyline; Rats; Serotonin; Spectrometry, Fluorescence | 1978 |
Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.
Topics: Adenylyl Cyclases; Amitriptyline; Animals; Brain; Clomipramine; Dibenzazepines; Fluoxetine; Male; Norepinephrine; Propylamines; Rats; Serotonin | 1978 |
Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats.
Topics: Animals; Body Temperature Regulation; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Injections, Intraperitoneal; Male; Propylamines; Rats; Serotonin Antagonists | 1978 |
Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine.
Topics: Animals; Clomipramine; Dibenzazepines; Fluoxetine; Guinea Pigs; Half-Life; Kinetics; Male; Myenteric Plexus; Neurons; Propylamines; Serotonin | 1979 |
Effects of increasing serotonergic receptor activity in brain on prostagladin E1-induced fever in rabbits.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Clomipramine; Fever; Fluoxetine; Injections, Intraperitoneal; Injections, Intraventricular; Male; Prostaglandins E; Rabbits; Receptors, Serotonin; Serotonin | 1979 |
Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.
Topics: Amphetamines; Animals; Clomipramine; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Male; Methysergide; Muscle Contraction; Pargyline; Rats; Serotonin | 1979 |
Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on 3H-serotonin receptor binding in rat brain.
Topics: Animals; Brain; Clomipramine; Clorgyline; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Rats; Receptors, Serotonin; Selegiline; Serotonin Antagonists | 1979 |
Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
Topics: Adolescent; Adult; Behavior, Addictive; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paraphilic Disorders; Psychiatric Status Rating Scales; Retrospective Studies; Serotonin | 1992 |
Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.
Topics: Animals; Biological Transport, Active; Blood Platelets; Clomipramine; Endothelium, Vascular; Fluoxetine; Lung; Male; Paroxetine; Piperidines; Plasma; Rats; Rats, Inbred Strains; Serotonin | 1992 |
Tricyclic antidepressant plasma levels after fluoxetine addition.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged | 1992 |
Treatment outcome of obsessive compulsive disorder with comorbid social phobia.
Topics: Adult; Clomipramine; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Phenelzine; Phobic Disorders; Probability; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1992 |
Antidepressants and the treatment of stuttering.
Topics: Antidepressive Agents; Clomipramine; Fluoxetine; Humans; Mianserin; Stuttering | 1992 |
Antidepressant-induced mania in obsessive-compulsive disorder.
Topics: Bipolar Disorder; Clomipramine; Fluoxetine; Humans; Norepinephrine; Obsessive-Compulsive Disorder; Serotonin | 1992 |
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.
Topics: Adult; Age Factors; Brain; Caudate Nucleus; Cerebral Cortex; Clomipramine; Female; Fluoxetine; Follow-Up Studies; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Tomography, Emission-Computed | 1992 |
Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
Topics: Adolescent; Clomipramine; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Trichotillomania | 1992 |
Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
Topics: Adolescent; Aggression; Carbamazepine; Child; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Paranoid Disorders | 1991 |
Fluoxetine treatment of obsessive-compulsive disorder.
Topics: Adult; Arousal; Clomipramine; Combined Modality Therapy; Depressive Disorder; Drive; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Personality Inventory | 1991 |
Interhemispheric serotonergic asymmetry reflected in topographic pharmaco-EEG.
Topics: Brain Mapping; Cerebral Cortex; Clomipramine; Depressive Disorder; Dominance, Cerebral; Electroencephalography; Evoked Potentials, Auditory; Female; Fluoxetine; Humans; Male; Middle Aged; Receptors, Serotonin; Serotonin | 1991 |
Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly.
Topics: Age Factors; Aged; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Tremor | 1991 |
Are effective antiobsessional drugs interchangeable?
Topics: Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Research Design; Serotonin Antagonists | 1991 |
Potential antidopaminergic effects of serotonin reuptake inhibitors.
Topics: Animals; Clomipramine; Dopamine Antagonists; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Rats; Schizophrenia; Serotonin Antagonists | 1991 |
Trichotillomania and depression.
Topics: Adolescent; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Stress, Psychological; Trichotillomania | 1991 |
Familial trichotillomania.
Topics: Adult; Clomipramine; Family; Female; Fluoxetine; Humans; Trichotillomania | 1991 |
Neurologic soft signs in obsessive-compulsive disorder.
Topics: Adult; Anxiety Disorders; Central Nervous System Diseases; Clomipramine; Clonidine; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Piperazines | 1991 |
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
Topics: Adult; Clomipramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Oximes; Serotonin Antagonists | 1990 |
Treatment of depersonalization with serotonin reuptake blockers.
Topics: Adolescent; Adult; Clomipramine; Depersonalization; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Oximes; Panic; Serotonin Antagonists | 1990 |
The pharmacotherapy of moral or religious scrupulosity.
Topics: Adolescent; Adult; Aged; Catholicism; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Judaism; Male; Middle Aged; Morals; Obsessive-Compulsive Disorder; Outcome and Process Assessment, Health Care; Psychiatric Status Rating Scales; Religion and Psychology | 1990 |
Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Clomipramine; Depression; Fluoxetine; Humans | 1990 |
Contribution of post-secretory mechanisms to the observed pattern of histamine and 5-hydroxytryptamine secretion from peritoneal rat mast cells in response to compound 48/80.
Topics: Amitriptyline; Animals; Biological Transport; Cell Separation; Clomipramine; Female; Fluoxetine; Histamine; Histamine Release; Mast Cells; Nialamide; Pargyline; Peritoneal Cavity; Phosphatidylserines; Rats; Rats, Inbred Strains; Secretory Rate; Serotonin; Temperature | 1989 |
Obsessive-compulsive disorder.
Topics: Adult; Behavior Therapy; Clomipramine; Diagnosis, Differential; Female; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Oximes; Physicians, Family; Serotonin Antagonists | 1989 |
Obsessive compulsive disorder.
Topics: Behavior Therapy; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Oximes | 1989 |
Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
Topics: Adult; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 1989 |
Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines.
Topics: Analgesia; Animals; Antidepressive Agents, Tricyclic; Clomipramine; Desipramine; Drug Interactions; Fluoxetine; Male; Morphine; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Opioid; Serotonin; Time Factors | 1988 |
The effect of altered 5-hydroxytryptamine levels on beta-endorphin content in rat brain.
Topics: 5,7-Dihydroxytryptamine; Adrenalectomy; Animals; beta-Endorphin; Brain; Clomipramine; Endorphins; Fenclonine; Fluoxetine; Hypothalamus; Periaqueductal Gray; Rats; Serotonin; Synaptic Transmission; Thalamus | 1986 |
Inhibition of sodium-dependent [3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors.
Topics: Animals; Cell Membrane; Cerebral Cortex; Clomipramine; Fluoxetine; Imipramine; Male; Rats; Receptors, Serotonin; Serotonin; Sodium; Trazodone | 1988 |
The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes.
Topics: Animals; Brain; Calcium; Citalopram; Clomipramine; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Potassium; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes | 1988 |
Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.
Topics: Adult; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; Self Mutilation | 1987 |
Antiobsessive effect of fluoxetine.
Topics: Clomipramine; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Propylamines; Psychiatric Status Rating Scales | 1985 |
5-Hydroxytryptamine uptake and imipramine binding sites in neurotumor NCB-20 cells.
Topics: Animals; Binding Sites; Brain; Clomipramine; Cricetinae; Cricetulus; Desipramine; Fluoxetine; Hybrid Cells; Imipramine; Iprindole; Kinetics; Mianserin; Neuroblastoma; Opipramol; Rats; Serotonin | 1985 |
Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Clomipramine; Corpus Striatum; Desipramine; Dopamine; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Nomifensine; Norepinephrine; Pyridines; Serotonin Antagonists | 1985 |
High-affinity uptake of serotonin into immunocytochemically identified astrocytes.
Topics: Animals; Astrocytes; Autoradiography; Biological Transport; Cells, Cultured; Clomipramine; Fluorescent Antibody Technique; Fluoxetine; Glial Fibrillary Acidic Protein; Rats; Serotonin; Sodium | 1985 |
Effects of 5-hydroxytryptamine, fluoxetine and chlorimipramine on reflex bradycardia in rats.
Topics: Animals; Blood Pressure; Bradycardia; Brain; Clomipramine; Dose-Response Relationship, Drug; Epinephrine; Fluoxetine; Heart Rate; Male; Propylamines; Rats; Receptors, Serotonin; Reflex; Serotonin; Urethane | 1980 |
Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
Topics: Animals; Biogenic Amines; Body Weight; Clomipramine; Dronabinol; Eating; Fluoxetine; Humans; Imipramine; Male; Rats; Substance Withdrawal Syndrome; Time Factors | 1980 |
Uptake and binding of serotonin by primary cultures of mouse astrocytes.
Topics: Animals; Astrocytes; Bucladesine; Cell Membrane; Cells, Cultured; Clomipramine; Fenfluramine; Fluoxetine; Kinetics; Mice; Serotonin | 1982 |
Hypothermia induced in rabbits by intracerebroventricular taurine: specificity and relationships with central serotonin (5-HT) systems.
Topics: Animals; Body Temperature Regulation; Brain Chemistry; Clomipramine; Fenclonine; Fever; Fluoxetine; Injections, Intraventricular; Male; Methysergide; Rabbits; Serotonin; Serotonin Antagonists; Skin Temperature; Taurine | 1981 |
Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
Topics: 5-Hydroxytryptophan; Animals; Clomipramine; Exploratory Behavior; Fluoxetine; Male; Methysergide; Motor Activity; Myoclonus; Propylamines; Rats; Serotonin | 1983 |
Effects of norepinephrine and serotonin uptake inhibitors on the schedule-controlled behavior of the pigeon.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Clomipramine; Columbidae; Conditioning, Operant; Desipramine; Doxepin; Fluoxetine; Iprindole; Male; Norepinephrine; Protriptyline; Reinforcement Schedule; Serotonin Antagonists | 1984 |
Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Animals; Benzofurans; Carbolines; Citalopram; Clomipramine; Clorgyline; Fluoxetine; Harmine; Indoles; Methoxydimethyltryptamines; Mice; Mice, Inbred DBA; N,N-Dimethyltryptamine; Pargyline; Propylamines; Quipazine; Seizures; Selegiline | 1980 |
Antidepressants and the control of predatory behavior.
Topics: Animals; Appetitive Behavior; Clomipramine; Dose-Response Relationship, Drug; Ferrets; Fluoxetine; Imipramine; Male; Predatory Behavior; Propylamines; Reaction Time | 1980 |
The filum terminale of the frog spinal cord, a nontransformed glial preparation: II. Uptake of serotonin.
Topics: Animals; Biological Transport; Cauda Equina; Clomipramine; Desipramine; Dihydroxytryptamines; Fluoxetine; Kinetics; Neuroglia; Rana pipiens; Serotonin; Sodium | 1981 |
Studies on a neuronal-like transport system for serotonin in two cell lines.
Topics: Animals; Cell Line; Clomipramine; Female; Fluoxetine; Kinetics; Mice; Neurons; Pregnancy; Serotonin | 1982 |
Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Disseminated Intravascular Coagulation; Drug Overdose; Fatal Outcome; Female; Fever; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Multiple Organ Failure; Selective Serotonin Reuptake Inhibitors; Syndrome | 1995 |
Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Clomipramine; Desipramine; Flunitrazepam; Fluoxetine; Ketanserin; Male; Maprotiline; Phenelzine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, GABA-A; Receptors, Serotonin; Serotonin Antagonists | 1995 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Behavior Therapy; Child; Child, Preschool; Clomipramine; Comorbidity; Data Collection; Family; Female; Fluoxetine; Humans; Male; Mental Disorders; Prevalence; Psychotherapy; Sex Distribution; Trichotillomania | 1995 |
[Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
Topics: Clomipramine; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Personality Disorders; Prognosis; Psychiatric Status Rating Scales; Schizophrenia | 1995 |
Fluoxetine-clomipramine interaction.
Topics: Adult; Clomipramine; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Seizures | 1995 |
Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
Topics: Animals; Brain; Clomipramine; Desipramine; Fluoxetine; Male; Motor Activity; Norepinephrine; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors | 1994 |
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
Topics: Animals; Clomipramine; Conditioning, Operant; Desipramine; Diazepam; Disease Models, Animal; Drinking Behavior; Fluoxetine; Haloperidol; Male; Obsessive-Compulsive Disorder; Rats; Rats, Wistar; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors | 1993 |
[A case of rare side effects of certain antidepressive drugs].
Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Fluoxetine; Humans; Male; Malignant Hyperthermia; Maprotiline; Parkinson Disease, Secondary; Substance-Related Disorders; Tremor | 1995 |
Chlorimipramine and nortriptyline but not fluoxetine and fluvoxamine inhibit human polymorphonuclear cell chemotaxis in vitro.
Topics: Antidepressive Agents; Chemotaxis, Leukocyte; Clomipramine; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neutrophils; Nortriptyline | 1994 |
Discontinuing obsessive-compulsive disorder medication with behavior therapy.
Topics: Adult; Behavior Therapy; Clomipramine; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Recurrence; Treatment Outcome | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Treatment of obsessive-compulsive symptoms in schizophrenia with a neuroleptic-selective serotonin reuptake inhibitor combination: two case reports.
Topics: Adult; Aged; Antipsychotic Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
Topics: Adult; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Severity of Illness Index | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone | 1994 |
Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications.
Topics: Adult; Awareness; Body Image; Clomipramine; Delusions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Models, Psychological; Pimozide; Selective Serotonin Reuptake Inhibitors | 1993 |
Comorbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes.
Topics: Absenteeism; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Comorbidity; Cost of Illness; Cross-Sectional Studies; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Work Capacity Evaluation | 1993 |
Individual differences in cerebral metabolic patterns during pharmacotherapy in obsessive-compulsive disorder: a multiple regression/discriminant analysis of positron emission tomographic data.
Topics: Adult; Brain; Clomipramine; Discriminant Analysis; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Regression Analysis; Time Factors; Tomography, Emission-Computed | 1993 |
Serotonin reuptake blockers for the treatment of obsessional jealousy.
Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealousy; Male; Obsessive-Compulsive Disorder; Pimozide; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sexual dysfunction during antidepressant treatment.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Incidence; Male; Middle Aged; Orgasm; Pain; Patient Compliance; Retrospective Studies; Sexual Dysfunctions, Psychological | 1993 |
Drug-induced mania.
Topics: Bipolar Disorder; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Risk Factors | 1993 |
Effect of naloxone and antidepressants on hyperphagia produced by peptide YY.
Topics: Animals; Antidepressive Agents; Clomipramine; Dose-Response Relationship, Drug; Feeding Behavior; Female; Fluoxetine; Gastrointestinal Hormones; Injections, Intraperitoneal; Injections, Intraventricular; Naloxone; Peptide YY; Peptides; Rats; Rats, Sprague-Dawley | 1993 |
Body dysmorphic disorder: 30 cases of imagined ugliness.
Topics: Adolescent; Adult; Age Factors; Aged; Agoraphobia; Anxiety Disorders; Body Image; Clomipramine; Delusions; Depressive Disorder; Family; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotropic Drugs; Suicide, Attempted | 1993 |
Postpartum obsessive compulsive disorder: a case series.
Topics: Adult; Clomipramine; Desipramine; Diagnosis, Differential; Female; Fluoxetine; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotic Disorders; Puerperal Disorders | 1993 |
The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Recurrence | 1993 |
Effect of antidepressants on striatal and accumbens extracellular dopamine levels.
Topics: Animals; Antidepressive Agents; Clomipramine; Corpus Striatum; Dopamine; Fluoxetine; Imipramine; Male; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors | 1995 |
Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clomipramine; Depression; Disease Models, Animal; Escape Reaction; Fluoxetine; Imipramine; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Time Factors | 1995 |
Tardive dyskinesia associated with fluoxetine.
Topics: Adult; Clomipramine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Trazodone | 1996 |
Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Carrageenan; Clomipramine; Dinoprostone; Dose-Response Relationship, Drug; Edema; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors.
Topics: Adult; Clomipramine; Cyproheptadine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological | 1995 |
Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.
Topics: Alcohol Withdrawal Delirium; Buspirone; Clomipramine; Diagnosis, Differential; Drug Therapy, Combination; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Myoclonus; Obsessive-Compulsive Disorder; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1996 |
Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Calcium; Clomipramine; Fluoxetine; Histamine Release; Mast Cells; p-Methoxy-N-methylphenethylamine; Peritoneum; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin | 1996 |
Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Fluoxetine; France; Humans; Male; Middle Aged; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 1996 |
Depression as a dynamical disease.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Arousal; Brain; Cerebral Cortex; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Electroencephalography; Female; Fluoxetine; Fourier Analysis; Humans; Male; Middle Aged; Models, Theoretical; Personality Inventory; Recurrence; Signal Processing, Computer-Assisted | 1996 |
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Metabolic interaction between fluoxetine and clomipramine: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Tachycardia, Sinus | 1996 |
Antidepressant induced mania in obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Clomipramine; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder | 1996 |
Juvenile obsessive-compulsive disorder.
Topics: Adolescent; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Personality Assessment; Prognosis; Treatment Outcome | 1997 |
Serotonin syndrome presenting with migrainelike stroke.
Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Clomipramine; Confusion; Drug Interactions; Female; Fluoxetine; Half-Life; Humans; Migraine Disorders; Obsessive-Compulsive Disorder; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1997 |
Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Clomipramine; Fluoxetine; Humans; Imipramine; Maprotiline; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1997 |
Olfactory reference syndrome responds to clomipramine but not fluoxetine: a case report.
Topics: Adult; Clomipramine; Comorbidity; Delusions; Depressive Disorder; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Somatoform Disorders | 1997 |
Treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1998 |
In vivo evaluation of serotonergic agents and alpha-adrenergic blockers on premature ejaculation by inhibiting the seminal vesicle pressure response to electrical nerve stimulation.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Clomipramine; Dose-Response Relationship, Drug; Ejaculation; Electric Stimulation; Fluoxetine; Imipramine; Male; Prazosin; Pressure; Rats; Rats, Wistar; Seminal Vesicles; Serotonin; Serotonin Agents; Sexual Dysfunction, Physiological; Splanchnic Nerves; Sympatholytics | 1998 |
Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception.
Topics: Amino Acid Sequence; Animals; Base Sequence; Biological Transport; Brain Stem; Carrier Proteins; Clomipramine; Cloning, Molecular; Desipramine; DNA, Complementary; Fluoxetine; Guinea Pigs; HeLa Cells; Humans; Imipramine; Intestinal Mucosa; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Nerve Tissue Proteins; Neurons; Peristalsis; Polymerase Chain Reaction; Rats; Recombinant Proteins; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Transcription, Genetic; Zimeldine | 1998 |
Milnacipran: new preparation. Tricyclics remain first-line antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclopropanes; Drug Evaluation; Europe; Fluoxetine; Fluvoxamine; Humans; Imipramine; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States | 1998 |
Fluoxetine for clomipramine withdrawal symptoms.
Topics: Adult; Clomipramine; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Male; Panic Disorder; Substance Withdrawal Syndrome | 1999 |
Olanzapine-induced obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clomipramine; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Schizophrenia | 1999 |
Treatment of obsessive-compulsive disorder using clomipramine in a very old patient.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Heart Diseases; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 1999 |
[Proofs of efficacy].
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Clomipramine; Comorbidity; Controlled Clinical Trials as Topic; Factor Analysis, Statistical; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Placebo Effect; Placebos; Probability; Psychiatric Status Rating Scales; Regression Analysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Treatment Outcome | 1999 |
New behavioral approach to trichotillomania.
Topics: Adolescent; Adult; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Trichotillomania | 1999 |
Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Case-Control Studies; Clomipramine; Depressive Disorder; Female; Fluoxetine; Humans; Inositol 1,4,5-Trisphosphate; Male; Middle Aged; Paroxetine; Platelet Aggregation; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors | 1999 |
Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Brain; Caudate Nucleus; Clomipramine; Drug Administration Schedule; Fluoxetine; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred Strains; Moclobemide; Raphe Nuclei; Serotonin; Time Factors; Tryptophan | 1999 |
Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2000 |
Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography.
Topics: Chromatography, Gas; Clomipramine; Drug Stability; Fluoxetine; Fluvoxamine; Pharmaceutical Preparations; Quality Control; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Solutions; Temperature | 2000 |
Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Clomipramine; Depressive Disorder, Major; Fluoxetine; Humans; Imipramine; Selective Serotonin Reuptake Inhibitors | 2000 |
Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro.
Topics: Animals; Antidepressive Agents; Brain; Cell Division; Cells, Cultured; Cerebellum; Clomipramine; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Nervous System; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Thymidine | 2001 |
Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Humans; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2001 |
Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat.
Topics: Aggression; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Defecation; Electric Stimulation; Electrodes, Implanted; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Periaqueductal Gray; Rats; Rats, Wistar; Urination | 2001 |
Development of a depersonalization severity scale.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Depersonalization; Desipramine; Discriminant Analysis; Female; Fluoxetine; Humans; Interview, Psychological; Male; Observer Variation; Psychiatric Status Rating Scales; Psychometrics; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2001 |
In-patient treatment for resistant obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Combined Modality Therapy; Desensitization, Psychologic; Female; Fluoxetine; Hospitalization; Humans; Obsessive-Compulsive Disorder; Saudi Arabia; Treatment Outcome | 2000 |
Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Aggression; Animals; Arginine Vasopressin; Behavior, Animal; Clomipramine; Cricetinae; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Grooming; Hair; Hypothalamus; Male; Microinjections; Obsessive-Compulsive Disorder; Pigmentation; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2001 |
Acute effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked unconditioned defensive behaviours of the rat.
Topics: Animals; Behavior, Animal; Clomipramine; Conditioning, Psychological; Defense Mechanisms; Electric Stimulation; Fluoxetine; Male; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2002 |
Calcium channel blocking activity of thioridazine, clomipramine and fluoxetine in isolated rat vas deferens: a relative potency measurement study.
Topics: Animals; Antidepressive Agents; Calcium; Calcium Channel Blockers; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; In Vitro Techniques; Male; Muscle Contraction; Nifedipine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Thioridazine; Vas Deferens | 2002 |
Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fluoxetine; Fluvoxamine; Male; Maprotiline; Mice; Motor Activity; Neurons; Norepinephrine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synaptic Transmission | 2002 |
Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report.
Topics: Adult; Clomipramine; Drug Resistance; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 2002 |
Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.
Topics: Adult; Benzodiazepines; Clomipramine; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Schizophrenia | 2003 |
Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat.
Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Carrageenan; Clomipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Imipramine; Inflammation; Male; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sertraline; Trazodone | 2003 |
Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats.
Topics: Animals; Anxiety; Autoradiography; Avoidance Learning; Behavior, Animal; Binding, Competitive; Brain; Central Nervous System; Citalopram; Clomipramine; Depression; Fluoxetine; Male; Microdialysis; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Synaptic Transmission; Tritium | 2003 |
Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Clomipramine; Depressive Disorder; Escape Reaction; Female; Fluoxetine; Helplessness, Learned; Male; Motor Activity; Pregnancy; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sex Factors; Urinary Bladder; Urination; Urination Disorders; Urodynamics | 2003 |
Chronic, but not acute, clomipramine or fluoxetine treatment reduces the spontaneous firing rate in the mesoaccumbens neurons of the rat.
Topics: Action Potentials; Animals; Antidepressive Agents; Clomipramine; Drug Administration Schedule; Fluoxetine; Male; Neurons; Nucleus Accumbens; Rats; Rats, Wistar; Time Factors | 2003 |
Serotonin uptake and metabolism by cultured guinea pig airway smooth muscle cells.
Topics: Animals; Cells, Cultured; Clomipramine; Fluoxetine; Fluvoxamine; Guinea Pigs; Muscle, Smooth; Selective Serotonin Reuptake Inhibitors; Serotonin; Trachea | 2004 |
In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Hypogastric Plexus; In Vitro Techniques; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Seminal Vesicles; Serotonin; Sertraline; Vas Deferens | 2004 |
Testosterone-dependent antidepressant-like effect of noradrenergic but not of serotonergic drugs.
Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Clomipramine; Desipramine; Female; Fluoxetine; Male; Motor Activity; Norepinephrine; Orchiectomy; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Swimming; Testosterone | 2004 |
Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD.
Topics: Child; Clomipramine; Cognitive Behavioral Therapy; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Fluoxetine; Injections, Subcutaneous; Motor Activity; Nicotine; Nicotinic Agonists; Pregnancy; Rats; Rats, Wistar; Serotonin; Swimming | 2005 |
Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Clomipramine; Female; Fluoxetine; Maternal-Fetal Exchange; Morphine Dependence; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2005 |
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Burkitt Lymphoma; Cell Line, Tumor; Clomipramine; Fenfluramine; Fluoxetine; Humans; Lymphoma, B-Cell; N-Methyl-3,4-methylenedioxyamphetamine; Proto-Oncogene Proteins c-bcl-2; Psychotropic Drugs; Serotonin Plasma Membrane Transport Proteins | 2005 |
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amino Acid Sequence; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blotting, Western; Cadmium; Cell Line; Cell Membrane; Citalopram; Clomipramine; Cocaine; Cysteine; Dopamine Uptake Inhibitors; Fluoxetine; HeLa Cells; Humans; Immunoprecipitation; Isoleucine; Kinetics; LLC-PK1 Cells; Mazindol; Methionine; Mice; Models, Chemical; Molecular Sequence Data; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Nomifensine; Protein Binding; Protein Structure, Tertiary; Protein Transport; Radiopharmaceuticals; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Stereoisomerism; Substrate Specificity; Tyrosine | 2006 |
Cognitive behavioral therapy versus psychosurgery for refractory obsessive-compulsive disorder.
Topics: Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Gyrus Cinguli; Humans; Middle Aged; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Psychosurgery | 2006 |
Oral contraceptive pill use and changes in obsessive-compulsive symptoms.
Topics: Adult; Clomipramine; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Premenstrual Syndrome; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2006 |
Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Clomipramine; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Narcolepsy; Polysomnography; Saudi Arabia | 2006 |
Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake.
Topics: Animals; Brain; Clomipramine; Dose-Response Relationship, Drug; Eating; Fluoxetine; Ghrelin; Hippocampus; Male; Memory; Models, Biological; Peptide Hormones; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2007 |
L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Treatment Outcome | 2007 |
The effects of antidepressants on cyclic AMP-response element-driven gene transcription in a model cell system.
Topics: Alkaline Phosphatase; Animals; Antidepressive Agents, Tricyclic; Blotting, Western; CHO Cells; Clomipramine; Cricetinae; Cricetulus; Cyclic AMP Response Element-Binding Protein; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Genes, Reporter; Humans; Receptors, Adrenergic, beta-2; Thiazepines; Time Factors; Transcription, Genetic | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Clinical inquiries. What's the best drug treatment for premature ejaculation?
Topics: Anesthetics, Local; Antidepressive Agents; Clomipramine; Ejaculation; Fluoxetine; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Paroxetine; Phosphodiesterase Inhibitors; Prilocaine; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Psychogenic excoriation responding to fluoxetine: a case report.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Behavior Therapy; Clomipramine; Compulsive Behavior; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Self Mutilation; Self-Injurious Behavior; Skin; Skin Diseases; Treatment Outcome | 2008 |
Male sexual dysfunction in unconsummated marriage: long-term outcome in 417 patients.
Topics: Adolescent; Adult; Aged; Clomipramine; Erectile Dysfunction; Female; Fluoxetine; Follow-Up Studies; Humans; Iran; Male; Marriage; Middle Aged; Papaverine; Phentolamine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Sex Education; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Social Values; Young Adult | 2008 |
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Connecticut; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Psychometrics; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2010 |
Evaluating the role of the serotoninergic system in the control of human seminal vesicle smooth muscle-an in vitro approach.
Topics: Adrenergic alpha-Agonists; Aged; Clomipramine; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Imipramine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Seminal Vesicles; Serotonin; Sexual Dysfunction, Physiological; Vas Deferens | 2009 |
Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Behavior, Animal; Cholinergic Agonists; Circadian Rhythm; Clomipramine; Corticosterone; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Muscarinic Agonists; Oxotremorine; Pituitary-Adrenal System; Rats; Rats, Wistar; Time Factors | 2010 |
SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.
Topics: Animals; Cell Proliferation; Cells, Cultured; Clomipramine; Fluoxetine; Humans; L Cells; Lymphoma, B-Cell; Mice; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2010 |
Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Clomipramine; Depression; Desipramine; Disease Models, Animal; Fluoxetine; Genetics, Behavioral; Phenotype; Rats; Rats, Inbred Strains; Stress, Psychological; Swimming | 2010 |
The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria.
Topics: Animals; Antidepressive Agents; CHO Cells; Clomipramine; Cricetinae; Cricetulus; Desipramine; Electron Transport Chain Complex Proteins; Fluoxetine; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Oxygen Consumption; Rats; Rats, Wistar; Thiazepines | 2011 |
Predictive validity of a non-induced mouse model of compulsive-like behavior.
Topics: Animals; Anxiety; Behavior, Animal; Clomipramine; Compulsive Behavior; Desipramine; Disease Models, Animal; Exploratory Behavior; Fluoxetine; Male; Maze Learning; Mice; Mice, Inbred Strains; Motor Activity; Nesting Behavior | 2011 |
Antidepressant-like effects of an alkaloid extract of the aerial parts of Annona cherimolia in mice.
Topics: Alkaloids; Animals; Annona; Antidepressive Agents; Behavior, Animal; Brain; Clomipramine; Dopamine; Fluoxetine; Herb-Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Imipramine; Male; Medicine, Traditional; Mexico; Mice; Plant Components, Aerial; Plant Extracts; Serotonin; Swimming | 2012 |
Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
Topics: Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Clomipramine; Clozapine; Comorbidity; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2012 |
Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Avoidance Learning; Behavior, Animal; Clomipramine; Data Interpretation, Statistical; Depression; Desipramine; Fluoxetine; Male; Motor Activity; Rats; Selective Serotonin Reuptake Inhibitors; Species Specificity; Stress, Psychological; Swimming | 2014 |
Inhibition of P-glycoprotein by psychotherapeutic drugs in a canine cell model.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Clomipramine; Dogs; Fluoxetine; Gene Expression Regulation; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Selegiline | 2014 |
An improved analytical strategy combining microextraction by packed sorbent combined with ultra high pressure liquid chromatography for the determination of fluoxetine, clomipramine and their active metabolites in human urine.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Clomipramine; Fluoxetine; Humans; Limit of Detection; Solid Phase Microextraction | 2015 |
Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives.
Topics: Animals; Aorta, Thoracic; Chickens; Clomipramine; Fluoxetine; Fluvoxamine; In Vitro Techniques; Male; Methamphetamine; p-Chloroamphetamine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2016 |
Paroxetine suppresses recombinant human P2X7 responses.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Interleukin-1beta; Lipopolysaccharide Receptors; Mice; Monocytes; Paroxetine; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Recombinant Proteins; Trifluoperazine | 2015 |
Recurrent brief depressive disorder in Dhat syndrome: A biological or psychological phenomenon!
Topics: Adult; Clomipramine; Cognitive Behavioral Therapy; Depressive Disorder; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychophysiologic Disorders | 2016 |
Improved Analytical Approach Based on QuECHERS/UHPLC-PDA for Quantification of Fluoxetine, Clomipramine and their Active Metabolites in Human Urine Samples.
Topics: Antidepressive Agents; Calibration; Chromatography, High Pressure Liquid; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Limit of Detection; Mass Spectrometry; Reproducibility of Results | 2017 |
Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations.
Topics: Animals; Antidepressive Agents; Blood-Brain Barrier; Cell Survival; Cells, Cultured; Clomipramine; Endothelial Cells; Energy Metabolism; Fluoxetine; Glutathione; Lactic Acid; Male; Membrane Potential, Mitochondrial; Oxidative Stress; Oxygen Consumption; Rats; Reactive Oxygen Species; Sertraline | 2017 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Female; Fluoxetine; GABA Modulators; Humans; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2017 |
FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: An in-silico study.
Topics: Citalopram; Clomipramine; Duloxetine Hydrochloride; Fluoxetine; Humans; Sertraline; United States | 2023 |